Pfizer And Allergan To Merge In $160 Billion Deal To Create World’s Largest Pharma Corporation

CNBC reports:

Pfizer announced Monday it will buy Allergan for $363.63 a share, or about $160 billion. The deal represents a premium of over 30 percent based on the companies’ unaffected shares price as of Oct. 28, Pfizer and Allergan said in a joint statement. Allergan shareholders will receive 11.3 shares of the combined company — Pfizer PLC — for each Allergan share, while current Pfizer shareholders will receive one share of the new company for each share they own. The deal, the largest ever in the health care sector, is expected to close in second half of nest year. It is also sure to draw political ire in a U.S. presidential election year because Pfizer would redomicile to Ireland, where Allergan is registered, in a so-called “inversion” that would slash its corporate tax rate.

Bernie Sanders is going to go nuts.